Shares of LHC Group (NASDAQ:LHCG) have earned an average rating of “Buy” from the thirteen ratings firms that are presently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The average 12 month price target among brokers that have covered the stock in the last year is $76.89.
LHCG has been the topic of a number of recent research reports. Zacks Investment Research raised shares of LHC Group from a “hold” rating to a “buy” rating and set a $79.00 price target on the stock in a research note on Wednesday, November 8th. Royal Bank Of Canada reaffirmed a “buy” rating and set a $70.00 price target on shares of LHC Group in a research note on Wednesday, September 6th. Bank of America started coverage on shares of LHC Group in a research note on Monday, August 21st. They set a “buy” rating and a $76.00 price target on the stock. BidaskClub upgraded shares of LHC Group from a “hold” rating to a “buy” rating in a research report on Friday, August 18th. Finally, Craig Hallum reiterated a “buy” rating and set a $80.00 price objective (up previously from $67.00) on shares of LHC Group in a research report on Tuesday, November 7th.
LHC Group (NASDAQ LHCG) traded up $0.01 during trading on Thursday, reaching $63.91. 326,390 shares of the company were exchanged, compared to its average volume of 148,853. The stock has a market capitalization of $1,150.85, a P/E ratio of 27.02, a price-to-earnings-growth ratio of 1.87 and a beta of 0.69. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24. LHC Group has a 52 week low of $41.66 and a 52 week high of $76.14.
LHC Group (NASDAQ:LHCG) last released its quarterly earnings results on Monday, November 6th. The health services provider reported $0.64 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.60 by $0.04. The company had revenue of $272.90 million for the quarter, compared to the consensus estimate of $265.35 million. LHC Group had a net margin of 4.09% and a return on equity of 9.52%. LHC Group’s revenue was up 18.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.54 earnings per share. sell-side analysts anticipate that LHC Group will post 2.4 EPS for the current year.
In other LHC Group news, COO Donald Dwayne Stelly sold 2,650 shares of the business’s stock in a transaction on Friday, September 8th. The shares were sold at an average price of $65.34, for a total transaction of $173,151.00. Following the transaction, the chief operating officer now owns 109,235 shares in the company, valued at $7,137,414.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 14.80% of the company’s stock.
Hedge funds have recently bought and sold shares of the business. Federated Investors Inc. PA increased its position in LHC Group by 4.2% during the second quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock valued at $110,000 after acquiring an additional 66 shares during the last quarter. Acrospire Investment Management LLC grew its holdings in shares of LHC Group by 30.8% in the second quarter. Acrospire Investment Management LLC now owns 1,700 shares of the health services provider’s stock worth $115,000 after purchasing an additional 400 shares during the last quarter. Cubist Systematic Strategies LLC grew its holdings in shares of LHC Group by 758.0% in the second quarter. Cubist Systematic Strategies LLC now owns 1,716 shares of the health services provider’s stock worth $116,000 after purchasing an additional 1,516 shares during the last quarter. First Mercantile Trust Co. bought a new position in shares of LHC Group in the second quarter worth about $147,000. Finally, SG Americas Securities LLC bought a new position in shares of LHC Group in the third quarter worth about $163,000. Institutional investors and hedge funds own 85.51% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This news story was originally published by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this news story on another domain, it was stolen and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://www.thelincolnianonline.com/2017/12/07/lhc-group-lhcg-receives-average-recommendation-of-buy-from-brokerages.html.
About LHC Group
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.